NCT02412059View on ClinicalTrials.gov

Topical Use of Corticosteroid to Prevent Epiretinal Membrane Following Retinal Tear

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Epiretinal Membrane
Interventions
DRUG

Prednisolone acetate

All Listed Sponsors
collaborator

University of Toronto

OTHER

lead

Unity Health Toronto

OTHER

NCT02412059 - Topical Use of Corticosteroid to Prevent Epiretinal Membrane Following Retinal Tear | Biotech Hunter | Biotech Hunter